Arcus Biosciences (RCUS) Cash from Operations Growth (1y) (2018 - 2026)
Arcus Biosciences (RCUS) Cash from Operations Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,725.60 Bn | 68,725.31 Bn | - | 7.14% |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 472.73 Bn | 467.94 Bn | 1.35 Bn | 356.73% |
| 5 | Vertex Pharmaceuticals | 123.52 Bn | 116.27 Bn | 2.59 Bn | 74.39% |
| 6 | Regeneron Pharmaceuticals | 69.74 Bn | 60.99 Bn | 3.31 Bn | 3.23% |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - | - |
| 8 | Argenx Se | 56.42 Bn | 51.24 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.76 Bn | 37.76 Bn | - | - |
| 10 | Arcus Biosciences | 3.66 Bn | 2.83 Bn | - | -4.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.55% |
| Dec 31, 2025 | -20.00% |
| Sep 30, 2025 | -473.08% |
| Jun 30, 2025 | -41.49% |
| Mar 31, 2025 | -6,500.00% |
| Dec 31, 2024 | -13.64% |
| Sep 30, 2024 | 141.27% |
| Jun 30, 2024 | -64.91% |
| Mar 31, 2024 | 97.96% |
| Dec 31, 2023 | -25.71% |
| Sep 30, 2023 | 22.22% |
| Jun 30, 2023 | 12.31% |
| Mar 31, 2023 | -114.98% |
| Dec 31, 2022 | -13.03% |
| Sep 30, 2022 | -50.68% |
| Jun 30, 2022 | 12.16% |
| Mar 31, 2022 | 1,086.19% |
| Dec 31, 2021 | -23.74% |
| Sep 30, 2021 | -124.86% |
| Jun 30, 2021 | -209.11% |